Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Invitation Homes Inc. Common Stock (INVH) vs Stryker Corporation (SYK) Price & Performance

Invitation Homes Inc. Common StockTrade
Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Invitation Homes Inc. Common Stock vs Stryker Corporation — how do they compare? Invitation Homes Inc. Common Stock trades at $26.54 (market cap $15.70B), while Stryker Corporation trades at $282 (market cap $108.38B). The key difference: Stryker Corporation is far larger — about 6.9× Invitation Homes Inc. Common Stock's market cap, and Invitation Homes Inc. Common Stock pays the higher dividend (4.51%). Which is the better fit depends on your goals — on Pluang, investors hold Invitation Homes Inc. Common Stock for 0 Days and Stryker Corporation for 22 Days on average.

INVHSYK
Market Cap
$15.70B$108.38B
Volume
4,685,4162,068,363
Sector
Real EstateHealth
52-Week High
$30.59$388.35
52-Week Low
$24.39$269.75
Typical Hold Time
0 Days22 Days
Enterprise Value
$24.16B$119.84B
Dividend Yield
4.51%1.25%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Invitation Homes Inc. Common Stock

INVH trades at $26.59, down 0.41% on the day, with neutral technical signals and strong fundamental performance. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results expected soon. Revenue growth from $2.73B in 2025 to $2.9B projected for 2026 supports a solid profit margin expansion to 23.13%. Analyst consensus remains bullish with a $31.67 price target, representing 19% upside potential from current levels.

The investment case centers on INVH's consistent earnings outperformance and robust single-family rental demand, though rising interest rates pose headwinds. With 56% of analysts recommending Buy and institutional accumulation continuing, the stock offers value at current levels despite technical consolidation. Key risks include interest rate sensitivity and regulatory changes affecting institutional homebuying.

Stryker Corporation

Stryker (SYK) trades at $282.63, showing minimal daily movement. The stock exhibits a neutral technical stance with mixed moving averages and oscillators. Fundamentally, SYK maintains strong profitability with a 14.43% net income margin and 16.51% ROE, though a P/E of 29.28 suggests a premium valuation. Recent news highlights ongoing legal scrutiny over a manufacturing issue disclosed in September 2026, which caused a significant price drop. Q3 2026 earnings are anticipated on October 29, 2026, following a mix of beats and misses in prior quarters.

The outlook for SYK is cautiously optimistic, supported by analyst consensus with a $365.89 price target and no sell ratings. Investment appeal lies in its solid cash flow and market position, but risks include legal investigations and persistent operational challenges. The stock's near-term direction will likely hinge on Q3 earnings results and clarity on the manufacturing issue resolution.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INVH
100% Buy0% Sell
Avg holding period · 0 Days
SYK
100% Buy0% Sell
Avg holding period · 22 Days

Top news

Latest headlines on both assets

About Invitation Homes Inc. Common Stock

Invitation Homes Inc. is a real estate investment trust that acquires, renovates, and leases single-family rental homes across roughly 19 US markets concentrated in Western and Southeastern US. It manages its portfolio through a pod-based local operating model supported by a maintenance technology platform.

Read more on INVH →

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK →